Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and...
58 insider purchases on record · latest filing 2024-04-12.
Insiders have also filed 18 sale transactions at LGVN.